Huiling Wang
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparable immune escape capacity between KP.2 and other SARS-CoV-2 variants in the central Chinese population after the first COVID-19 booster.
Journal: Scientific reports
Published: February 13, 2025
Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: a multicentre, prospective, longitudinal cohort study.
Journal: Frontiers in immunology
Published: June 10, 2024
Drug-drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS.
Journal: Expert opinion on drug safety
Published: July 21, 2023
Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database.
Journal: Expert opinion on drug safety
Published: September 30, 2022
An Overview of Nucleic Acid Testing for the Novel Coronavirus SARS-CoV-2.
Journal: Frontiers in medicine
Published: June 23, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China.
Journal: Frontiers in cellular and infection microbiology
Published: May 14, 2020
A fullerene based hybrid nanoparticle facilitates enhanced photodynamic therapy via changing light source and oxygen consumption.
Journal: Colloids and surfaces. B, Biointerfaces
Published: August 16, 2019
Cascade catalytic nanoplatform for enhanced starvation and sonodynamic therapy.
Journal: Journal of drug targeting
Published: July 09, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026